Agreement between Bharat Biotech and Gujarat Kovid Vaccine Consortium: Hester – haste agreement between bharat biotech and gujarat kovid vaccine consortium
Hester Biosciences said in a notice to the stock market on Thursday that the Gujarat Biotechnology Research Center (GRBC) at GCVC, Hester Biosciences and Omnibrics Biotechnologies Pvt. Ltd. Are included.
He said that under the agreement, India will share the technology of the actual material used in the manufacture of biotech Kovacsin. GRBC will act as an advisor and mentor and facilitate Bharat Biotech technology transfer.
It said Hester would provide the complete infrastructure at its Gujarat plant for manufacturing the drug, while Omnibrux would act as a technology support partner.
He said, “If all continues on schedule, the material used in the vaccine will be available from August 2021 and will be given back to Bharat Biotech for the production of covaxine.”
Hester said it has estimated an outlay of Rs 40 crore for the project.
#Agreement #Bharat #Biotech #Gujarat #Kovid #Vaccine #Consortium #Hester #haste #agreement #bharat #biotech #gujarat #kovid #vaccine #consortium